Pharmacophore/Receptor Models for GABAA/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach-Reference-Cited by-同舟云学术

Pharmacophore/Receptor Models for GABAA/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach

Published:1999-12-09 Issue:1 Volume:43 Page:71-95
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Huang Qi¹,He Xiaohui¹,Ma Chunrong¹,Liu Ruiyan¹,Yu Shu¹,Dayer Charlotte A.¹,Wenger Galen R.¹,McKernan Ruth¹,Cook James M.¹

Affiliation:

1. Department of Chemistry, University of Wisconsin−Milwaukee, P.O. Box 413, Milwaukee, Wisconsin 53201, Department of Pharmacology & Toxicology, University of Arkansas for Medical Sciences/Mail Slot 611, 4301 West Markham Street, Little Rock, Arkansas 72205, and Department of Biochemistry, Merck Sharpe and Dohme Research Laboratories, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm990341r

Reference173 articles.

1. Benzodiazepine Receptor: Demonstration in the Central Nervous System

2. Benzodiazepine receptors in rat brain

3. Soluble benzodiazepine receptors: Gabaergic regulation

4. Benzodiazepine Receptor-Mediated Experimental "Anxiety" in Primates

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular effects of midazolam, flumazenil, and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta;Canadian Journal of Physiology and Pharmacology;2023-11-01

2. Terminal Alkyne-Modified DNA Aptamers with Enhanced Protein Binding Affinities;ACS Chemical Biology;2023-08-02

3. Antidepressant Activities of Synthesized Benzodiazepine Analogues in Mice;Brain Sciences;2023-03-21

4. Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers;Drug and Alcohol Dependence;2023-02

5. The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders;Pharmacology Biochemistry and Behavior;2022-02